{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:59:18Z","timestamp":1754153958094,"version":"3.41.2"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"2023 Jinhua Science and Technology Research Plan Public Welfare Projects","award":["2023-4-079","2023-4-079","2023-4-079"],"award-info":[{"award-number":["2023-4-079","2023-4-079","2023-4-079"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03208-5","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T18:11:59Z","timestamp":1753294319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of cell adhesion related signature for molecular subtyping and prognostic prediction in acute myeloid leukemia"],"prefix":"10.1007","volume":"16","author":[{"given":"Caifang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"issue":"3","key":"3208_CR1","first-page":"38","volume":"103","author":"A Pelcovits","year":"2020","unstructured":"Pelcovits A, Niroula R. Acute myeloid leukemia: a review. Rhode Island Med J (2013). 2020;103(3):38\u201340.","journal-title":"Rhode Island Med J (2013)"},{"issue":"1","key":"3208_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3322\/caac.21873","volume":"75","author":"HM Kantarjian","year":"2025","unstructured":"Kantarjian HM, DiNardo CD, Kadia TM, Daver NG, Altman JK, Stein EM, et al. Acute myeloid leukemia management and research in 2025. Cancer J Clin. 2025;75(1):46\u201367. https:\/\/doi.org\/10.3322\/caac.21873.","journal-title":"Cancer J Clin"},{"key":"3208_CR3","doi-asserted-by":"crossref","unstructured":"Forsberg M, Konopleva M. AML treatment: conventional chemotherapy and emerging novel agents, Trends in pharmacological sciences. 2024;45(5): 430-448.10.1016\/j.tips.2024.03.005.","DOI":"10.1016\/j.tips.2024.03.005"},{"key":"3208_CR4","doi-asserted-by":"publisher","first-page":"106727","DOI":"10.1016\/j.leukres.2021.106727","volume":"111","author":"D Padmakumar","year":"2021","unstructured":"Padmakumar D, Chandraprabha VR, Gopinath P, Vimala Devi ART, Anitha GRJ, Sreelatha MM, et al. A concise review on the molecular genetics of acute myeloid leukemia. Leuk Res. 2021;111:106727. https:\/\/doi.org\/10.1016\/j.leukres.2021.106727.","journal-title":"Leuk Res"},{"issue":"9","key":"3208_CR5","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nrm2957","volume":"11","author":"JT Parsons","year":"2010","unstructured":"Parsons JT, Horwitz AR, Schwartz MA. Cell adhesion: integrating cytoskeletal dynamics and cellular tension. Nat Rev Mol Cell Biol. 2010;11(9):633\u201343. https:\/\/doi.org\/10.1038\/nrm2957.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3208_CR6","doi-asserted-by":"publisher","first-page":"756231","DOI":"10.3389\/fimmu.2021.756231","volume":"12","author":"JMP Grenier","year":"2021","unstructured":"Grenier JMP, Testut C, Fauriat C, Mancini SJC, Aurrand-Lions M. Adhesion molecules involved in stem cell niche retention during normal haematopoiesis and in acute myeloid leukaemia. Front Immunol. 2021;12:756231. https:\/\/doi.org\/10.3389\/fimmu.2021.756231.","journal-title":"Front Immunol"},{"issue":"11","key":"3208_CR7","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.3324\/haematol.2009.013730","volume":"94","author":"EC Forsberg","year":"2009","unstructured":"Forsberg EC, Smith-Berdan S. Parsing the niche code: the molecular mechanisms governing hematopoietic stem cell adhesion and differentiation. Haematologica. 2009;94(11):1477\u201381. https:\/\/doi.org\/10.3324\/haematol.2009.013730.","journal-title":"Haematologica"},{"issue":"2","key":"3208_CR8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/bph.16149","volume":"181","author":"HA Ogana","year":"2024","unstructured":"Ogana HA, Hurwitz S, Wei N, Lee E, Morris K, Parikh K, et al. Targeting integrins in drug-resistant acute myeloid leukaemia. Br J Pharmacol. 2024;181(2):295\u2013316. https:\/\/doi.org\/10.1111\/bph.16149.","journal-title":"Br J Pharmacol"},{"issue":"4","key":"3208_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.21037\/atm-23-1824","volume":"12","author":"AP Urs","year":"2024","unstructured":"Urs AP, Goda C, Kulkarni R. Remodeling of the bone marrow microenvironment during acute myeloid leukemia progression. Annals Translational Med. 2024;12(4):63. https:\/\/doi.org\/10.21037\/atm-23-1824.","journal-title":"Annals Translational Med"},{"key":"3208_CR10","doi-asserted-by":"publisher","unstructured":"Windisch R, Pirschtat N, Kellner C, Chen-Wichmann L, Lausen J, Humpe A, et al. Oncogenic deregulation of cell adhesion molecules in leukemia. Cancers. 2019;11(3). https:\/\/doi.org\/10.3390\/cancers11030311.","DOI":"10.3390\/cancers11030311"},{"key":"3208_CR11","doi-asserted-by":"publisher","first-page":"751834","DOI":"10.3389\/fonc.2021.751834","volume":"11","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Chen J, Wang J, Guan W, Wang M, Zhang L, et al. Acute myeloid leukemia epigenetic immune escape from nature killer cells by ICAM-1. Front Oncol. 2021;11:751834. https:\/\/doi.org\/10.3389\/fonc.2021.751834.","journal-title":"Front Oncol"},{"issue":"5","key":"3208_CR12","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/bjh.16456","volume":"189","author":"EE Ladikou","year":"2020","unstructured":"Ladikou EE, Chevassut T, Pepper CJ, Pepper AG. Dissecting the role of the CXCL12\/CXCR4 axis in acute myeloid leukaemia. Br J Haematol. 2020;189(5):815\u201325. https:\/\/doi.org\/10.1111\/bjh.16456.","journal-title":"Br J Haematol"},{"issue":"6","key":"3208_CR13","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1194\/jlr.M091876","volume":"60","author":"SF Tan","year":"2019","unstructured":"Tan SF, Dunton W, Liu X, Fox TE, Morad SAF, Desai D, et al. Acid ceramidase promotes drug resistance in acute myeloid leukemia through NF-\u03baB-dependent P-glycoprotein upregulation. J Lipid Res. 2019;60(6):1078\u201386. https:\/\/doi.org\/10.1194\/jlr.M091876.","journal-title":"J Lipid Res"},{"key":"3208_CR14","doi-asserted-by":"crossref","unstructured":"He X, Wang L, Zeng W, Wang Y, Chen N, Yang P et al. Regulatable C-X-C chemokine receptor type 4 in iPSC-derived NK cells improves bone marrow chemotaxis and targeting resident tumor, Trends in biotechnology. 2025.10.1016\/j.tibtech.2025.02.018.","DOI":"10.1016\/j.tibtech.2025.02.018"},{"key":"3208_CR15","doi-asserted-by":"publisher","unstructured":"Gruszka AM, Valli D, Restelli C, Alcalay M. Adhesion deregulation in acute myeloid leukaemia. Cells. 2019;8(1). https:\/\/doi.org\/10.3390\/cells8010066.","DOI":"10.3390\/cells8010066"},{"key":"3208_CR16","doi-asserted-by":"crossref","unstructured":"Sykes SM. NCAM1 supports therapy resistance and LSC function in AML, Blood. 2019;133(21): 2247-2248.10.1182\/blood-2019-03-901017.","DOI":"10.1182\/blood-2019-03-901017"},{"key":"3208_CR17","doi-asserted-by":"crossref","unstructured":"Gebru MT, Wang HG. Therapeutic targeting of FLT3 and associated drug resistance in acute myeloid leukemia, Journal of hematology & oncology. 2020;13(1): 155.10.1186\/s13045-020-00992-1.","DOI":"10.1186\/s13045-020-00992-1"},{"key":"3208_CR18","doi-asserted-by":"crossref","unstructured":"Harjunp\u00e4\u00e4 H, Llort Asens M, Guenther C, Fagerholm SC. Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment, Frontiers in immunology. 2019;10: 1078.10.3389\/fimmu.2019.01078.","DOI":"10.3389\/fimmu.2019.01078"},{"key":"3208_CR19","doi-asserted-by":"publisher","unstructured":"Hu FF, Liu CJ, Liu LL, Zhang Q, Guo AY. Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response. Brief Bioinform. 2021;22(3). https:\/\/doi.org\/10.1093\/bib\/bbaa176.","DOI":"10.1093\/bib\/bbaa176"},{"issue":"1","key":"3208_CR20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13045-022-01328-x","volume":"15","author":"W Li","year":"2022","unstructured":"Li W, Wang F, Guo R, Bian Z, Song Y. Targeting macrophages in hematological malignancies: recent advances and future directions. J Hematol Oncol. 2022;15(1):110. https:\/\/doi.org\/10.1186\/s13045-022-01328-x.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"3208_CR21","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.cmet.2017.01.001","volume":"25","author":"Y Fan","year":"2017","unstructured":"Fan Y, Hanai JI, Le PT, Bi R, Maridas D, DeMambro V, et al. Parathyroid hormone directs bone marrow mesenchymal cell fate. Cell Metabol. 2017;25(3):661\u201372. https:\/\/doi.org\/10.1016\/j.cmet.2017.01.001.","journal-title":"Cell Metabol"},{"issue":"6","key":"3208_CR22","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1182\/blood.2021013156","volume":"139","author":"CP Mill","year":"2022","unstructured":"Mill CP, Fiskus W, DiNardo CD, Birdwell C, Davis JA, Kadia TM, et al. Effective therapy for AML with RUNX1 mutation by cotreatment with inhibitors of protein translation and BCL2. Blood. 2022;139(6):907\u201321. https:\/\/doi.org\/10.1182\/blood.2021013156.","journal-title":"Blood"},{"issue":"10","key":"3208_CR23","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1200\/jco.2010.30.7926","volume":"29","author":"VI Gaidzik","year":"2011","unstructured":"Gaidzik VI, Bullinger L, Schlenk RF, Zimmermann AS, R\u00f6ck J, Paschka P, et al. RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study group. J Clin Oncology: Official J Am Soc Clin Oncol. 2011;29(10):1364\u201372. https:\/\/doi.org\/10.1200\/jco.2010.30.7926.","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"key":"3208_CR24","doi-asserted-by":"publisher","unstructured":"Eissmann MF, Dijkstra C, Jarnicki A, Phesse T, Brunnberg J, Poh A.R., et al. IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization. Nat Commun. 2019;10(1):2735. https:\/\/doi.org\/10.1038\/s41467-019-10676-1.","DOI":"10.1038\/s41467-019-10676-1"},{"key":"3208_CR25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/978-981-10-3233-2_11","volume":"962","author":"S Lin","year":"2017","unstructured":"Lin S, Mulloy JC, Goyama S. RUNX1-ETO leukemia. Adv Exp Med Biol. 2017;962:151\u201373. https:\/\/doi.org\/10.1007\/978-981-10-3233-2_11.","journal-title":"Adv Exp Med Biol"},{"issue":"7","key":"3208_CR26","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.1007\/s12325-021-01809-4","volume":"38","author":"J Kast","year":"2021","unstructured":"Kast J, Dutta S, Upreti VV. Panitumumab: A review of clinical Pharmacokinetic and Pharmacology properties after over a decade of experience in patients with solid tumors. Adv Therapy. 2021;38(7):3712\u201323. https:\/\/doi.org\/10.1007\/s12325-021-01809-4.","journal-title":"Adv Therapy"},{"key":"3208_CR27","unstructured":"Chidharla A, Parsi M, Kasi A, Cetuximab SP. StatPearls Publishing Copyright \u00a9 2025, StatPearls Publishing LLC., Treasure Island (FL) ineligible companies. Disclosure: Meghana Parsi declares no relevant financial relationships with ineligible companies. Disclosure: Anup Kasi declares no relevant financial relationships with ineligible companies., 2025."},{"issue":"4","key":"3208_CR28","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s12288-020-01274-z","volume":"36","author":"S Nath","year":"2020","unstructured":"Nath S, Bhattacharyya J, Sarma PP, Saxena R, Sazawal S, Barman MP, et al. The prognostic impact of epidermal growth factor receptor (EGFR) in patients with acute myeloid leukaemia. Indian J Hematol Blood Transfusion: Official J Indian Soc Hematol Blood Transfus. 2020;36(4):749\u201353. https:\/\/doi.org\/10.1007\/s12288-020-01274-z.","journal-title":"Indian J Hematol Blood Transfusion: Official J Indian Soc Hematol Blood Transfus"},{"key":"3208_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fonc.2020.00033","volume":"10","author":"J Chen","year":"2020","unstructured":"Chen J, Liu H, Chen J, Sun B, Wu J, Du C. PLXNC1 enhances carcinogenesis through transcriptional activation of IL6ST in gastric Cancer. Front Oncol. 2020;10:33. https:\/\/doi.org\/10.3389\/fonc.2020.00033.","journal-title":"Front Oncol"},{"issue":"5","key":"3208_CR30","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.prp.2019.01.030","volume":"215","author":"Q Xia","year":"2019","unstructured":"Xia Q, Zhou Y, Yong H, Wang X, Zhao W, Ding G, et al. Elevated Epiregulin expression predicts poor prognosis in gastric cancer. Pathol Res Pract. 2019;215(5):873\u20139. https:\/\/doi.org\/10.1016\/j.prp.2019.01.030.","journal-title":"Pathol Res Pract"},{"key":"3208_CR31","doi-asserted-by":"publisher","first-page":"1161835","DOI":"10.3389\/fmed.2023.1161835","volume":"10","author":"T Li","year":"2023","unstructured":"Li T, Feng R, Chen B, Zhou J. EREG is a risk factor for the prognosis of patients with cervical cancer. Front Med. 2023;10:1161835. https:\/\/doi.org\/10.3389\/fmed.2023.1161835.","journal-title":"Front Med"},{"key":"3208_CR32","doi-asserted-by":"publisher","unstructured":"L Q., C Y., Y Y., S Q. A Treg-related riskscore model May improve the prognosis evaluation of colorectal cancer. J Gene Med. 2024;26(2):e3668. https:\/\/doi.org\/10.1002\/jgm.3668.","DOI":"10.1002\/jgm.3668"},{"issue":"3","key":"3208_CR33","doi-asserted-by":"publisher","first-page":"455","DOI":"10.12182\/20230560101","volume":"54","author":"XL Jie","year":"2023","unstructured":"Jie XL, Kong YY, Zhou GB. Latest findings on the role of CD47 in tumor immune evasion and related targeted therapies. Sichuan Da Xue Xue Bao Yi Xue ban = J Sichuan Univ Med Sci Ed. 2023;54(3):455\u201361. https:\/\/doi.org\/10.12182\/20230560101.","journal-title":"Sichuan Da Xue Xue Bao Yi Xue ban = J Sichuan Univ Med Sci Ed"},{"issue":"8","key":"3208_CR34","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3779\/j.issn.1009-3419.2024.106.23","volume":"27","author":"R Chen","year":"2024","unstructured":"Chen R, Yang X, Liu Q, Zhang S, Ma L. Research progresses on the effects of CCL4 on immune escape in tumor microenvironment. Zhongguo Fei Ai Za zhi = Chin J Lung cancer. 2024;27(8):613\u201321. https:\/\/doi.org\/10.3779\/j.issn.1009-3419.2024.106.23.","journal-title":"Zhongguo Fei Ai Za zhi = Chin J Lung cancer"},{"key":"3208_CR35","doi-asserted-by":"crossref","unstructured":"L\u00e4ubli H, Borsig L. Altered Cell Adhesion and Glycosylation Promote Cancer Immune Suppression and Metastasis, Frontiers in immunology. 2019;10: 2120.10.3389\/fimmu.2019.02120.","DOI":"10.3389\/fimmu.2019.02120"},{"key":"3208_CR36","doi-asserted-by":"crossref","unstructured":"Okabe A, Kaneda A. Transcriptional dysregulation by aberrant enhancer activation and rewiring in cancer, Cancer science. 2021;112(6): 2081-2088.10.1111\/cas.14884.","DOI":"10.1111\/cas.14884"},{"key":"3208_CR37","doi-asserted-by":"crossref","unstructured":"Yerlikaya A, Kanbur E. The Ubiquitin-Proteasome Pathway and Resistance Mechanisms Developed Against the Proteasomal Inhibitors in Cancer Cells, Current drug targets. 2020;21(13): 1313-1325.10.2174\/1389450121666200525004714.","DOI":"10.2174\/1389450121666200525004714"},{"key":"3208_CR38","doi-asserted-by":"crossref","unstructured":"Yerlikaya A, Kanbur E, Stanley BA, T\u00fcmer E. The Ubiquitin-Proteasome Pathway and Epigenetic Modifications in Cancer, Anti-cancer agents in medicinal chemistry. 2021;21(1): 20-32.10.2174\/1871520620666200811114159.","DOI":"10.2174\/1871520620666200811114159"},{"key":"3208_CR39","doi-asserted-by":"crossref","unstructured":"Wang YL, Lee CC, Shen YC, Lin PL, Wu WR, Lin YZ et al. Evading immune surveillance via tyrosine phosphorylation of nuclear PCNA, Cell reports. 2021;36(8): 109537.10.1016\/j.celrep.2021.109537.","DOI":"10.1016\/j.celrep.2021.109537"},{"key":"3208_CR40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-3-031-30146-9_14","volume-title":"Cancer, getting to know your cells","author":"L Saucedo","year":"2023","unstructured":"Saucedo L. Cancer, getting to know your cells. Cham: Springer International Publishing; 2023. pp. 79\u201384."},{"key":"3208_CR41","doi-asserted-by":"crossref","unstructured":"Turrin NP, Plata-Salam\u00e1n CR. Cytokine-cytokine interactions and the brain, Brain research bulletin. 2000;51(1): 3-9.10.1016\/s0361-9230(99)00203-8.","DOI":"10.1016\/S0361-9230(99)00203-8"},{"key":"3208_CR42","doi-asserted-by":"crossref","unstructured":"Serramito-G\u00f3mez I, Boada-Romero E, Villamuera R, Fern\u00e1ndez-Cabrera \u00c1, Cedillo JL, Mart\u00edn-Regalado \u00c1 et al. Regulation of cytokine signaling through direct interaction between cytokine receptors and the ATG16L1 WD40 domain, Nature communications. 2020;11(1): 5919.10.1038\/s41467-020-19670-4.","DOI":"10.1038\/s41467-020-19670-4"},{"key":"3208_CR43","doi-asserted-by":"crossref","unstructured":"Chen X, Fu E, Lou H, Mao X, Yan B, Tong F et al. IL-6 induced M1 type macrophage polarization increases radiosensitivity in HPV positive head and neck cancer, Cancer letters. 2019;456: 69-79.10.1016\/j.canlet.2019.04.032.","DOI":"10.1016\/j.canlet.2019.04.032"},{"key":"3208_CR44","doi-asserted-by":"crossref","unstructured":"Zhou J, Chooi JY, Ching YQ, Quah JY, Toh SH, Ng Y et al. NF-\u03baB promotes the stem-like properties of leukemia cells by activation of LIN28B, World journal of stem cells. 2018;10(4): 34-42.10.4252\/wjsc.v10.i4.34.","DOI":"10.4252\/wjsc.v10.i4.34"},{"key":"3208_CR45","doi-asserted-by":"crossref","unstructured":"Witalisz-Siepracka A, Denk CM, Zd\u00e1rsky B, Hofmann L, Edtmayer S, Harm T et al. STAT3 in acute myeloid leukemia facilitates natural killer cell-mediated surveillance, Frontiers in immunology. 2024;15: 1374068.10.3389\/fimmu.2024.1374068.","DOI":"10.3389\/fimmu.2024.1374068"},{"key":"3208_CR46","doi-asserted-by":"crossref","unstructured":"Siddique MH, Bukhari S, Khan IU, Essa A, Ali Z, Sabir U et al. In Silico, In Vitro, and In Vivo Evaluation of Caffeine-Coated Nanoparticles as a Promising Therapeutic Avenue for AML through NF-Kappa B and TRAIL Pathways Modulation, Pharmaceuticals (Basel, Switzerland). 2023;16(12).10.3390\/ph16121742.","DOI":"10.3390\/ph16121742"},{"key":"3208_CR47","doi-asserted-by":"crossref","unstructured":"Ravindran M, Khan MA, Palaniyar N. Neutrophil Extracellular Trap Formation: Physiology, Pathology, and Pharmacology, Biomolecules. 2019;9(8).10.3390\/biom9080365.","DOI":"10.3390\/biom9080365"},{"key":"3208_CR48","doi-asserted-by":"crossref","unstructured":"Munir H, Jones JO, Janowitz T, Hoffmann M, Euler M, Martins CP et al. Stromal-driven and Amyloid \u03b2-dependent induction of neutrophil extracellular traps modulates tumor growth, Nature communications. 2021;12(1): 683.10.1038\/s41467-021-20982-2.","DOI":"10.1038\/s41467-021-20982-2"},{"key":"3208_CR49","doi-asserted-by":"crossref","unstructured":"Wang CY, Lin SC, Chang KJ, Cheong HP, Wu SR, Lee CH et al. Immunoediting in acute myeloid leukemia: Reappraising T cell exhaustion and the aberrant antigen processing machinery in leukemogenesis, Heliyon. 2024;10(21): e39731.10.1016\/j.heliyon.2024.e39731.","DOI":"10.1016\/j.heliyon.2024.e39731"},{"key":"3208_CR50","doi-asserted-by":"crossref","unstructured":"Zhou H, Jia B, Annageldiyev C, Minagawa K, Zhao C, Mineishi S et al. CD26(low)PD-1(+) CD8 T cells are terminally exhausted and associated with leukemia progression in acute myeloid leukemia, Frontiers in immunology. 2023;14: 1169144.10.3389\/fimmu.2023.1169144.","DOI":"10.3389\/fimmu.2023.1169144"},{"key":"3208_CR51","doi-asserted-by":"crossref","unstructured":"Rakebrandt N, Yassini N, Kolz A, Schorer M, Lambert K, Goljat E et al. Innate acting memory Th1 cells modulate heterologous diseases, Proceedings of the National Academy of Sciences of the United States of America. 2024;121(24): e2312837121.10.1073\/pnas.2312837121.","DOI":"10.1073\/pnas.2312837121"},{"key":"3208_CR52","doi-asserted-by":"crossref","unstructured":"Weinh\u00e4user I, Pereira-Martins DA, Almeida LY, Hilberink JR, Silveira DRA, Quek L et al. M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism, Science advances. 2023;9(15): eadf8522.10.1126\/sciadv.adf8522.","DOI":"10.1126\/sciadv.adf8522"},{"key":"3208_CR53","doi-asserted-by":"crossref","unstructured":"Al-Matary YS, Botezatu L, Opalka B, H\u00f6nes JM, Lams RF, Thivakaran A et al. Acute myeloid leukemia cells polarize macrophages towards a leukemia supporting state in a Growth factor independence 1 dependent manner, Haematologica. 2016;101(10): 1216-1227.10.3324\/haematol.2016.143180.","DOI":"10.3324\/haematol.2016.143180"},{"key":"3208_CR54","doi-asserted-by":"crossref","unstructured":"Dai H, Pena A, Bauer L, Williams A, Watkins SC, Camirand G. Treg suppression of immunity within inflamed allogeneic grafts, JCI insight. 2022;7(16).10.1172\/jci.insight.160579.","DOI":"10.1172\/jci.insight.160579"},{"key":"3208_CR55","doi-asserted-by":"crossref","unstructured":"Moreno Ayala MA, Li Z, DuPage M. Treg programming and therapeutic reprogramming in cancer, Immunology. 2019;157(3): 198-209.10.1111\/imm.13058.","DOI":"10.1111\/imm.13058"},{"key":"3208_CR56","doi-asserted-by":"crossref","unstructured":"Gao H, Zhou Y, Chen X. Tregs and Platelets Play Synergistic Roles in Tumor Immune Escape and Inflammatory Diseases, Critical reviews in immunology. 2022;42(2): 59-69.10.1615\/CritRevImmunol.2023047234.","DOI":"10.1615\/CritRevImmunol.2023047234"},{"key":"3208_CR57","doi-asserted-by":"crossref","unstructured":"Woo SR, Turnis ME, Goldberg MV, Bankoti J, Selby M, Nirschl CJ et al. Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape, Cancer research. 2012;72(4): 917\u2013\u200927.10.1158\/0008-5472.Can-11-1620.","DOI":"10.1158\/0008-5472.CAN-11-1620"},{"key":"3208_CR58","doi-asserted-by":"crossref","unstructured":"Ji S, Yu H, Zhou D, Fan X, Duan Y, Tan Y et al. Cancer stem cell-derived CHI3L1 activates the MAF\/CTLA4 signaling pathway to promote immune escape in triple-negative breast cancer, Journal of translational medicine. 2023;21(1): 721.10.1186\/s12967-023-04532-6.","DOI":"10.1186\/s12967-023-04532-6"},{"key":"3208_CR59","doi-asserted-by":"crossref","unstructured":"Aroldi F, Saleh R, Jafferji I, Barreto C, Saberian C, Middleton MR. Lag3: From Bench to Bedside, Cancer treatment and research. 2022;183: 185-199.10.1007\/978-3-030-96376-7_6.","DOI":"10.1007\/978-3-030-96376-7_6"},{"key":"3208_CR60","doi-asserted-by":"crossref","unstructured":"Maurer K, Park CY, Mani S, Borji M, Raths F, Gouin KH 3 et al. rd,., Coordinated immune networks in leukemia bone marrow microenvironments distinguish response to cellular therapy, Science immunology. 2025;10(103): eadr0782.10.1126\/sciimmunol.adr0782.","DOI":"10.1126\/sciimmunol.adr0782"},{"key":"3208_CR61","doi-asserted-by":"crossref","unstructured":"Shi C, Tian Z, Yan J, Zhang M, Sukhumalchandra P, Chang E et al. Immunotherapy targeting a leader sequence cathepsin G-derived peptide, Leukemia. 2025;39(4): 888-898.10.1038\/s41375-025-02520-x.","DOI":"10.1038\/s41375-025-02520-x"},{"key":"3208_CR62","doi-asserted-by":"crossref","unstructured":"Raby AC, Lab\u00e9ta MO. Therapeutic Boosting of the Immune Response: Turning to CD14 for Help, Current pharmaceutical biotechnology. 2016;17(5): 414\u2013\u20098.10.2174\/1389201017666160114095708.","DOI":"10.2174\/1389201017666160114095708"},{"key":"3208_CR63","doi-asserted-by":"crossref","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response, Nature medicine. 2018;24(10): 1550-1558.10.1038\/s41591-018-0136-1.","DOI":"10.1038\/s41591-018-0136-1"},{"key":"3208_CR64","doi-asserted-by":"crossref","unstructured":"Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D et al. Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade, Cell reports. 2017;18(1): 248-262.10.1016\/j.celrep.2016.12.019.","DOI":"10.1016\/j.celrep.2016.12.019"},{"key":"3208_CR65","doi-asserted-by":"crossref","unstructured":"Ouyang P, Wang L, Wu J, Tian Y, Chen C, Li D et al. Overcoming cold tumors: a combination strategy of immune checkpoint inhibitors, Frontiers in immunology. 2024;15: 1344272.10.3389\/fimmu.2024.1344272.","DOI":"10.3389\/fimmu.2024.1344272"},{"key":"3208_CR66","doi-asserted-by":"crossref","unstructured":"Zhang A, Fan T, Liu Y, Yu G, Li C, Jiang Z. Regulatory T cells in immune checkpoint blockade antitumor therapy, Molecular cancer. 2024;23(1): 251.10.1186\/s12943-024-02156-y.","DOI":"10.1186\/s12943-024-02156-y"},{"key":"3208_CR67","doi-asserted-by":"crossref","unstructured":"Chavanton A, Mialhe F, Abrey J, Baeza Garcia A, Garrido C. LAG-3: recent developments in combinational therapies in cancer, Cancer science. 2024;115(8): 2494-2505.10.1111\/cas.16205.","DOI":"10.1111\/cas.16205"},{"key":"3208_CR68","doi-asserted-by":"crossref","unstructured":"Qi Y, Chen L, Liu Q, Kong X, Fang Y, Wang J. Research Progress Concerning Dual Blockade of Lymphocyte-Activation Gene 3 and Programmed Death-1\/Programmed Death-1 Ligand-1 Blockade in Cancer Immunotherapy: Preclinical and Clinical Evidence of This Potentially More Effective Immunotherapy Strategy, Frontiers in immunology. 2020;11: 563258.10.3389\/fimmu.2020.563258.","DOI":"10.3389\/fimmu.2020.563258"},{"key":"3208_CR69","doi-asserted-by":"crossref","unstructured":"Ruiz-Aparicio PF, Vanegas NP, Uribe GI, Ortiz-Montero P, Cadavid-Cort\u00e9s C, Lagos J et al. Dual Targeting of Stromal Cell Support and Leukemic Cell Growth by a Peptidic PKC Inhibitor Shows Effectiveness against B-ALL, International journal of molecular sciences. 2020;21(10).10.3390\/ijms21103705.","DOI":"10.3390\/ijms21103705"},{"key":"3208_CR70","doi-asserted-by":"crossref","unstructured":"Yu CH, Chou CC, Tu HF, Huang WC, Ho YY, Khoo KH et al. Antibody-assisted target identification reveals afatinib, an EGFR covalent inhibitor, down-regulating ribonucleotide reductase, Oncotarget. 2018;9(30): 21512-21529.10.18632\/oncotarget.25177.","DOI":"10.18632\/oncotarget.25177"},{"key":"3208_CR71","doi-asserted-by":"crossref","unstructured":"Hsieh YT, Gang EJ, Shishido SN, Kim HN, Pham J, Khazal S et al. Effects of the small-molecule inhibitor of integrin \u03b14, TBC3486, on pre-B-ALL cells, Leukemia. 2014;28(10): 2101\u2013\u20094.10.1038\/leu.2014.182.","DOI":"10.1038\/leu.2014.182"},{"key":"3208_CR72","doi-asserted-by":"crossref","unstructured":"Ferreira EFB, Silva LB, Cruz JV, Ara\u00fajo PHF, Kimani NM, Leite FHA et al. An Overview of the \u03b14\u03b21 Integrin and the Potential Therapeutic Role of its Antagonists, Current medicinal chemistry. 2021;28(29): 5884-5895.10.2174\/0929867328666210217153609.","DOI":"10.2174\/0929867328666210217153609"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03208-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03208-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03208-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T18:12:14Z","timestamp":1753294334000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03208-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3208"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03208-5","relation":{},"ISSN":["2730-6011"],"issn-type":[{"type":"electronic","value":"2730-6011"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"15 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"1397"}}